Profile data is unavailable for this security.
About the company
Abingdon Health plc provides lateral flow contract development and manufacturing (CDMO services) and related contract services to an international customer base. It offers its services to an international customer base across industry sectors, which include clinical, self-testing, animal health, plant health, and environmental testing. Its segments include Product sales, Contract manufacturing, Contract development, and Regulatory. Its regulatory services include technical file build, regulatory filing support, implementation of quality management systems and quality assurance. The Company’s CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing.
- Revenue in GBP (TTM)5.34m
- Net income in GBP-2.24m
- Incorporated2008
- Employees82.00
- LocationAbingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
- Phone+44 190 440 6050
- Fax+44 190 446 2122
- Websitehttps://www.abingdonhealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rua Life Sciences PLC | 1.87m | -1.87m | 6.83m | 40.00 | -- | 0.6535 | -- | 3.65 | -0.0843 | -0.0843 | 0.0843 | 0.1683 | 0.3293 | 3.26 | 4.80 | 46,725.00 | -32.95 | -25.97 | -36.33 | -28.26 | 81.97 | -- | -100.05 | -110.53 | 2.40 | -61.71 | 0.1065 | -- | 34.09 | 40.08 | 3.10 | -- | 94.82 | -- |
| Cambridge Nutritional Sciences PLC | 9.05m | -3.21m | 8.45m | 91.00 | -- | 0.908 | -- | 0.9338 | -0.0136 | -0.0105 | 0.0385 | 0.0391 | 0.5857 | 3.97 | 2.05 | 99,406.59 | -20.81 | -10.49 | -23.88 | -11.90 | 52.90 | 59.24 | -35.53 | -27.40 | 4.22 | -128.47 | 0.0225 | -- | -11.63 | -1.96 | -125.12 | -- | -45.83 | -- |
| Genedrive PLC | 272.00k | -5.00m | 9.10m | 43.00 | -- | 1.70 | -- | 33.45 | -0.0407 | -0.0407 | 0.0022 | 0.0098 | 0.0658 | -- | 1.60 | 6,325.58 | -120.84 | -97.55 | -197.86 | -128.51 | -- | -- | -1,837.50 | -797.03 | 1.36 | -7.49 | 0.0789 | -- | 12.24 | -50.95 | -10.16 | -- | 16.72 | -- |
| Feedback plc | 886.00k | -3.49m | 9.13m | 24.00 | -- | 1.02 | -- | 10.31 | -0.2614 | -0.2614 | 0.0664 | 0.6726 | 0.0774 | -- | 3.74 | 36,916.67 | -30.44 | -28.58 | -32.67 | -31.74 | 90.60 | 92.61 | -393.47 | -299.13 | -- | -- | 0.00 | -- | 74.15 | 17.46 | -37.74 | -- | 56.22 | -- |
| Proteome Sciences plc | 5.03m | -2.44m | 11.07m | 35.00 | -- | -- | -- | 2.20 | -0.0083 | -0.0083 | 0.017 | -0.0104 | 0.4209 | 3.89 | 3.04 | 143,657.10 | -20.45 | -1.22 | -- | -- | 32.76 | 54.53 | -48.59 | -2.20 | 0.2667 | -2.03 | 1.29 | -- | -35.37 | 10.52 | -284.38 | -- | 126.22 | -- |
| Inspiration Healthcare Group PLC | 37.63m | -6.32m | 11.94m | 210.00 | -- | 0.4122 | -- | 0.3173 | -0.0925 | -0.0925 | 0.5516 | 0.4245 | 0.7243 | 1.67 | 3.66 | -- | -12.17 | 0.8965 | -14.86 | 1.10 | 47.53 | 47.61 | -16.80 | 0.9922 | 0.9698 | -0.9172 | 0.307 | -- | -8.74 | 19.43 | -2,423.90 | -- | 31.88 | -- |
| Genincode PLC | 2.16m | -7.02m | 11.95m | 36.00 | -- | 5.02 | -- | 5.53 | -0.0732 | -0.0732 | 0.0225 | 0.0135 | 0.2703 | 21.88 | 3.33 | 60,000.00 | -87.79 | -- | -124.10 | -- | 47.31 | -- | -324.81 | -- | 1.24 | -- | 0.1883 | -- | 51.05 | -- | -26.21 | -- | -- | -- |
| Abingdon Health PLC | 5.34m | -2.24m | 12.99m | 82.00 | -- | 6.88 | -- | 2.43 | -0.0184 | -0.0184 | 0.0439 | 0.0149 | 0.8978 | 7.67 | 4.74 | 65,170.73 | -37.55 | -51.31 | -58.04 | -79.85 | 57.35 | 33.16 | -41.82 | -139.64 | 1.59 | -- | 0.3572 | -- | 42.68 | -- | 83.77 | -- | -- | -- |
| Verici DX PLC | 795.13k | -6.86m | 15.77m | 14.00 | -- | 3.96 | -- | 19.83 | -0.0403 | -0.0403 | 0.0047 | 0.0164 | 0.0932 | -- | 1.59 | 56,795.29 | -80.32 | -- | -115.94 | -- | 1.58 | -- | -862.19 | -- | -- | -- | 0.0438 | -- | -- | -- | 23.43 | -- | -- | -- |
| Renalytix PLC | 2.67m | -36.28m | 16.98m | 80.00 | -- | 0.7122 | -- | 6.36 | -0.4441 | -0.4441 | 0.0325 | 0.1545 | 0.0646 | 2.88 | 4.06 | 33,388.96 | -87.73 | -58.25 | -120.00 | -67.03 | 20.60 | -- | -1,358.30 | -1,904.79 | 1.71 | -9.62 | 0.397 | -- | 14.58 | -- | 18.52 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Hargreaves Lansdown Asset Management Ltd.as of 08 Sep 2023 | 10.43m | 8.23% |
| Unicorn Asset Management Ltd.as of 31 May 2024 | 1.93m | 1.52% |
